BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12107945)

  • 1. [Celiac disease--a diagnostic and scientific challenge].
    Skovbjerg H; Sjöström H; Norén OB
    Ugeskr Laeger; 2002 Jun; 164(25):3329-33. PubMed ID: 12107945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening gor celiac disease can be justified in high-risk groups].
    Sjöberg K; Carlsson A
    Lakartidningen; 2004 Nov; 101(48):3912, 3915-6, 3918-9. PubMed ID: 15631226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency.
    Lenhardt A; Plebani A; Marchetti F; Gerarduzzi T; Not T; Meini A; Villanacci V; Martelossi S; Ventura A
    Dig Liver Dis; 2004 Nov; 36(11):730-4. PubMed ID: 15571003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease.
    Liu E; Li M; Emery L; Taki I; Barriga K; Tiberti C; Eisenbarth GS; Rewers MJ; Hoffenberg EJ
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):293-300. PubMed ID: 17873740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coeliac disease diagnosed at Starship Children's Hospital: 1999-2002.
    Westerbeek E; Mouat S; Wesley A; Chin S
    N Z Med J; 2005 Aug; 118(1220):U1613. PubMed ID: 16132074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit.
    Kaukinen K; Collin P; Laurila K; Kaartinen T; Partanen J; Mäki M
    Scand J Gastroenterol; 2007 Dec; 42(12):1428-33. PubMed ID: 17852878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies.
    Ch'ng CL; Biswas M; Benton A; Jones MK; Kingham JG
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):303-6. PubMed ID: 15730411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of celiac disease among family members of celiac disease patients.
    Dolinsek J; Urlep D; Karell K; Partanen J; Micetić-Turk D
    Wien Klin Wochenschr; 2004; 116 Suppl 2():8-12. PubMed ID: 15506303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors of celiac disease occurrence in type 1 diabetes mellitus children].
    Myśliwiec M; Balcerska A; Stepiński J; Bakowska A; Jedrzejczyk A; Bautembach-Minkowska J; Sztangierska B; Banach P; Wiśniewski P
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(4):281-5. PubMed ID: 17239306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene and gliadin/gut and kidney.
    Biagi F; Corazza GR
    Am J Gastroenterol; 2002 Oct; 97(10):2486-8. PubMed ID: 12385427
    [No Abstract]   [Full Text] [Related]  

  • 11. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
    Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relevance of anti-tissue transglutaminase antibodies in coeliac disease diagnosis].
    Lepers S; Soula F; Fily S; Fontaine E; Vuye S; Colombel JF; Guimber D; Prin L; Dubucquoi S
    Ann Biol Clin (Paris); 2003; 61(3):337-43. PubMed ID: 12805013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic screening for coeliac disease in risk groups: is once in the lifetime enough?
    Collin P; Kaukinen K
    Dig Liver Dis; 2008 Feb; 40(2):101-3. PubMed ID: 18083085
    [No Abstract]   [Full Text] [Related]  

  • 14. [Screening for adult celiac disease].
    Hovdenak N
    Tidsskr Nor Laegeforen; 1999 May; 119(13):1885-7. PubMed ID: 10382334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the evaluation and diagnosis of celiac disease.
    Leffler DA; Kelly CP
    Curr Opin Allergy Clin Immunol; 2006 Jun; 6(3):191-6. PubMed ID: 16670513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study.
    Gomez JC; Selvaggio G; Pizarro B; Viola MJ; La Motta G; Smecuol E; Castelletto R; Echeverria R; Vazquez H; Mazure R; Crivelli A; Sugai E; Mauriño E; Bai JC
    Am J Gastroenterol; 2002 Nov; 97(11):2785-90. PubMed ID: 12425549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celiac disease: from pathogenesis to novel therapies.
    Schuppan D; Junker Y; Barisani D
    Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Milestones in the immunopathogenesis of endemic sprue].
    Dreier G; Stüber E; Koop I
    Z Gastroenterol; 1999 Jan; 37(1):117-9. PubMed ID: 10091286
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of anti-transglutaminase antibodies in the diagnosis of coeliac disease in children: results of a five year prospective study].
    Laadhar L; Bouaziz N; Ben Ayed M; Chaabouni M; Boudawara T; Hachicha M; Jliri R; Triki A; Masmoudi H
    Ann Biol Clin (Paris); 2004; 62(4):431-6. PubMed ID: 15297237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serologic screening for coeliac disease].
    Rumessen JJ
    Ugeskr Laeger; 2004 May; 166(22):2142-4. PubMed ID: 15222165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.